12 West Capital Management LP Alnylam Pharmaceuticals, Inc. Transaction History

12 West Capital Management LP

  • $959 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$126.83 - $175.69 $93.2 Million - $129 Million
-735,000 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$88.31 - $107.8 $3.09 Million - $3.77 Million
35,000 Added 5.0%
735,000 $72.4 Million
Q3 2017

Nov 14, 2017
BUY
$72.53 - $118.27 $50.8 Million - $82.8 Million
700,000
700,000 $82.2 Million

Others Institutions Holding ALNY

# of Institutions
643
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29.9B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track 12 West Capital Management LP Portfolio

Follow 12 West Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 12 West Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on 12 West Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email